The clinical trial patient recruitment market involves various technologies and services that help in identifying, screening and enrolling eligible trial participants. Clinical trial patient recruitment has become increasingly challenging over the past years owing to factors such as complex trial protocols, geographical limitations and stiff competition among pharmaceutical companies for attracting participants. This has boosted the demand for patient recruitment technologies and services that help streamline screening processes and improve outreach. Various software solutions are being developed that leverage machine learning and artificial intelligence capabilities for analyzing huge patient databases and identifying best-fit candidates for a particular clinical study.
The clinical trial patient recruitment services market is estimated to be valued at USD 9.4 Bn in 2024 and is expected to reach USD 19.1 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.
Key Takeaways
Key players: Key players operating in the clinical trial patient recruitment market are IQVIA, Parexel International, Charles River, SGS, ICON PLC and Pfizer.
Key opportunities: The increasing R&D investments in drug development by pharmaceutical companies and growing adoption of decentralized and virtual clinical trials are expected to create lucrative opportunities for players in the Clinical Trial Patient Recruitment Services Market.
Technological advancements: Advancements in patient enrollment technologies that leverage artificial intelligence and machine learning are helping optimize patient identification and screening processes. chatbots and mobile applications for improving awareness about trials and reducing screening time are gaining popularity.
Market drivers:
Increasing prevalence of chronic and rare diseases:
The rising incidence of diseases like cancer, cardiovascular disease, diabetes is driving demand for developing new treatment options. This is positively impacting clinical trials and the need for patient recruitment.Growing geriatric population: older patients are more susceptible to chronic diseases. Their involvement in clinical trials is important. This vast patient pool is expected to drive recruitment volumes in the coming years.
Challenges in the Clinical Trial Patient Recruitment Industry
The clinical trial patient recruitment industry faces several challenges currently. Recruiting patients for clinical trials is becoming more difficult due to increased competition among pharmaceutical companies conducting trials. Patients also have less trust in the pharmaceutical industry today compared to past decades. Insufficient funding and long trial duration further impact patient recruitment numbers for many drug developers.
SWOT Analysis
Strength: Existing site network and experienced CROs have built relationships with patients and sites. This helps recruit patients faster.
Weakness: High costs involved in running late stage trials. Small biotechs have limited budgets which impacts patient recruitment.
Opportunity: Developing countries offer large patient pools but cultural and regulatory hurdles exist. If addressed, it can boost enrollment.
Threats: Stricter data privacy laws can limit data sharing needed for patient screening. Drug developers outsourcing more work lose control and insight into processes.North America accounted for the highest share in the clinical trial patient recruitment market in terms of value in the historical period owing to presence of large pharmaceutical companies, growing R&D expenditure, and rising number of clinical trials in the US and Canada. The Asia Pacific region is expected to grow at the fastest rate during the forecast period driven by rising medical tourism, lower costs for clinical trials, and presence of patient pools in China and India. China has emerged as the second largest market for clinical trial recruitment by value as it provides access to a huge patient pool and lower costs compared to developed markets. The country accounted for over 20% share of global trials conducted in 2020 and is expected to grow even faster in coming years supported by government initiatives and industry collaborations.
Get this Report in Japanese Language: 臨床試験患者募集サービス市場
Get this Report in Korean Language: 임상 시험 환자 모집 서비스 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
